Cellebrite DI Ltd. (CLBT)
(Delayed Data from NSDQ)
$16.64 USD
+0.13 (0.79%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $16.65 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$16.64 USD
+0.13 (0.79%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $16.65 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
Zacks News
Are Business Services Stocks Lagging Adyen (ADYEY) This Year?
by Zacks Equity Research
Here is how Adyen N.V. Unsponsored ADR (ADYEY) and Cellebrite DI Ltd. (CLBT) have performed compared to their sector so far this year.
Why Cellebrite DI Ltd. (CLBT) Might be Well Poised for a Surge
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Cellebrite DI Ltd. (CLBT) and Genpact (G) have performed compared to their sector so far this year.
Cellebrite DI Ltd. (CLBT) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cellebrite DI Ltd. (CLBT) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) delivered earnings and revenue surprises of 25% and 4.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
TTEC Holdings (TTEC) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
TTEC (TTEC) delivered earnings and revenue surprises of -51.72% and 3.71%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
R1 RCM Inc. (RCM) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
R1 RCM INC (RCM) delivered earnings and revenue surprises of 60% and 1.21%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Allot (ALLT) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Allot Communications (ALLT) and Cellebrite DI Ltd. (CLBT) have performed compared to their sector so far this year.
Cellebrite DI Ltd. (CLBT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Cellebrite DI Ltd. (CLBT) Soars 6.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) delivered earnings and revenue surprises of 33.33% and 4.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Arbe Robotics Ltd. (ARBE) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Industrial Tech Acquisitions (ARBE) delivered earnings and revenue surprises of -100% and 54.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
FUTU vs. CLBT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FUTU vs. CLBT: Which Stock Is the Better Value Option?
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Cellebrite DI Ltd. (CLBT) and MoneyLion Inc. (ML) have performed compared to their sector so far this year.
Are Business Services Stocks Lagging Cellebrite DI Ltd. (CLBT) This Year?
by Zacks Equity Research
Here is how Cellebrite DI Ltd. (CLBT) and CompoSecure, Inc. (CMPO) have performed compared to their sector so far this year.
Will Cellebrite DI Ltd. (CLBT) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Reasons to Add Maximus (MMS) Stock to Your Portfolio Now
by Zacks Equity Research
Maximus (MMS) maintains solid relationships and a strong reputation with governments.
Reasons to Retain Omnicom (OMC) Stock in Your Portfolio Now
by Zacks Equity Research
Omnicom (OMC) gains on acquisitions and presence across various segments amid foreign exchange fluctuations and low liquidity.
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Cellebrite DI Ltd. (CLBT) and Viant Technology (DSP) have performed compared to their sector so far this year.
VNT vs. CLBT: Which Stock Is the Better Value Option?
by Zacks Equity Research
VNT vs. CLBT: Which Stock Is the Better Value Option?
Is Cellebrite DI Ltd. (CLBT) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how Cellebrite DI Ltd. (CLBT) and Viant Technology (DSP) have performed compared to their sector so far this year.
Cellebrite DI Ltd. (CLBT) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Cellebrite DI Ltd. (CLBT) have what it takes to be a top stock pick for momentum investors? Let's find out.
VNT vs. CLBT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
VNT vs. CLBT: Which Stock Is the Better Value Option?
Are Business Services Stocks Lagging Cellebrite DI Ltd. (CLBT) This Year?
by Zacks Equity Research
Here is how Cellebrite DI Ltd. (CLBT) and Credo Technology Group Holding Ltd. (CRDO) have performed compared to their sector so far this year.
Surging Earnings Estimates Signal Upside for Cellebrite DI Ltd. (CLBT) Stock
by Zacks Equity Research
Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.